Your browser doesn't support javascript.
loading
Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation
Silva, Michael Ruberson Ribeiro da; Santos, Jéssica Barreto Ribeiro dos; Almeida, Alessandra Maciel; Alvares-Teodoro, Juliana; Kakehasi, Adriana Maria; Acurcio, Francisco de Assis.
Affiliation
  • Silva, Michael Ruberson Ribeiro da; Federal University of Minas Gerais. College of Pharmacy. Belo Horizonte. BR
  • Santos, Jéssica Barreto Ribeiro dos; Federal University of Minas Gerais. College of Pharmacy. Belo Horizonte. BR
  • Almeida, Alessandra Maciel; Federal University of Minas Gerais. College of Pharmacy. Belo Horizonte. BR
  • Alvares-Teodoro, Juliana; Federal University of Minas Gerais. College of Pharmacy. Belo Horizonte. BR
  • Kakehasi, Adriana Maria; Federal University of Minas Gerais. Medicine School. Belo Horizonte. BR
  • Acurcio, Francisco de Assis; Federal University of Minas Gerais. College of Pharmacy. Belo Horizonte. BR
Adv Rheumatol ; 59: 48, 2019. tab, graf
Article in En | LILACS | ID: biblio-1088620
Responsible library: BR1.1
ABSTRACT
Abstract

Background:

Pharmaceutical Assistance (PA) is a dynamic and multidisciplinary process that aims to supply health systems, programs or services with quality medicines, enabling access and health care, in an efficient and timely manner. The objective of the study was to evaluate the profile of administrative processes for the treatment of PsA, identify the time elapsed in the flow of processes and its associated factors.

Methods:

A cross-sectional study of medication requests for the treatment of PsA was carried out between November 2014 and December 2016. Linear regression was used to verify the factors associated with time to delivery.

Results:

A total of 218 cases containing 250 drugs were analyzed. The median time between the medical appointment and the first dispensation was 66 days (interquartile range, 44-90). The State proceedings, which includes requesting the drug until the authorization of treatment, was the stage that most contributed to the total time spent. The factors associated with the longer time to delivery of medications were prescriptions coming from clinics and specialty centers, from dermatologists, non-authorized processes and non-persistent patients in the treatment in 12 months.

Conclusion:

The median time to receive medicines for the PsA treatment in Belo Horizonte health region after a medical prescription was higher than 2 months. The time between the solicitation of the medicines and the authorization of the treatment in the SUS (State administrative procedure) was the main component of the total time spent.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Pharmaceutical Services / Unified Health System / Arthritis, Psoriatic / Drug Costs / Antirheumatic Agents / Health Policy Type of study: Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do sul / Brasil Language: En Journal: Adv Rheumatol Journal subject: Artrite / Reumatologia Year: 2019 Document type: Article Affiliation country: Brazil Country of publication: Brazil

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Pharmaceutical Services / Unified Health System / Arthritis, Psoriatic / Drug Costs / Antirheumatic Agents / Health Policy Type of study: Health_economic_evaluation / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: America do sul / Brasil Language: En Journal: Adv Rheumatol Journal subject: Artrite / Reumatologia Year: 2019 Document type: Article Affiliation country: Brazil Country of publication: Brazil